CTSV, a lysosomal cysteine protease, is expressed at increased levels in HCC and is an independent prognostic risk factor for HCC survival, and elevated CTSV expression is strongly correlated with an adverse prognosis in HCC (Jing et al., 2018). The gene discussed is CTSB; the disease is hepatocellular carcinoma.